June 3, 7:30am-9:30pm
June 4, 7:30am-7:30pm
June 5, 8:00am-3:30pm
Not available yet
Please remember that sites are responsible for covering travel expenses for their Community Advisory Board (CAB) representatives. This should be done in a manner that ensures CAB representatives have minimal cash outlay.
Interpretation will be provided on-site for some meetings (please be advised that if there is not sufficient demand for any language, this service may be canceled), especially those targeted toward CAB representatives. Anyone who might be interested in utilizing interpretation should request their native language when completing the conference registration form, so that we can be sure to have enough head-sets for everyone.
The long-term goal of the HIV Vaccine Trials Network (HVTN) in collaboration with the NIH Division of AIDS (DAIDS) is to develop a safe and efficacious vaccine to prevent HIV-1 infection. The Spring 2014 Full Group Meeting in Washington, DC will be an opportunity to welcome new and renewed NIAID funded clinical trial units and sites to the network and to refocus our vision and energies on the path ahead toward vaccine licensure. We look forward to gathering from our communities on five continents to continue the vital work of the HVTN .